StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Novartis' Beovu Label a Positive for Regeneron Pharma (REGN) - BMO
October 8, 2019 12:24 PM
BMO Capital analyst Matthew Luchini reiterated a Market Perform rating and $344.00 price target on Regeneron Pharma (NASDAQ: REGN), saying ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Regeneron Pharma (REGN) PT Lowered to $320 at Canaccord Genuity
October 8, 2019 11:35 AM